Fbc Hldg Inc- (FBCD) 0.0001 $FBCD FBC Holding Enters the

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fbc Hldg Inc- (FBCD) 0.0001 $FBCD

FBC Holding Enters the $11 Billion Social Media Industry With LOI to Boost Sales
Marketwired - Wed May 13, 7:31AM CDT
FBC Holding, Inc. (OTC PINK: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through direct-to-consumer marketing, announced that the company executed a letter of intent to acquire certain assets of a major national social media marketing firm.

FBC Holding Inc. CEO, Frank Russo, is Featured in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Thu Feb 19, 9:40AM CST
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with FBC Holding, Inc. (OTC:FBCD) (the "Company" , an international product and development company, is now available. The interview can be heard at http://smallcapvoice.com/blog/2-11-15-smallca...g-inc-fbcd

FBC Holding, Inc. CEO to Provide Shareholders Update
PR Newswire - Mon Feb 09, 3:40PM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) announced today is providing shareholders with an overview of the company's accomplishments in 2014 and its positioning for 2015.

Leigh Valentine Receives New Product Formulation Samples at North Carolina Headquarters
PR Newswire - Thu Jan 29, 7:48AM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) and its cosmetics arm, Leigh Valentine Beauty have announced they received samples of the Firming and Lifting Serum with the new formulation.

FBC Holding, Inc. Announces 47% Increase in Leigh Valentine Product Sales for December
PR Newswire - Thu Jan 15, 7:10AM CST
International product and development company FBC Holding, Inc. (OTC: FBCD) and its cosmetics arm, Leigh Valentine Beauty, have announced December sales for 2014 increased 47% over 2013 results.

FBC Holding, Inc. executes on Strategy in 2014, rolling into promising 2015
PR Newswire - Thu Jan 08, 7:10AM CST
FBC Holding, Inc. (OTC: FBCD) an international product development company has signed deals with COCO-AMO and Leigh Valentine Beauty during 2014. Both companies are well positioned in the health and beauty category going into 2015.

A New Audio Interview With FBC Holding, Inc., CEO Frank Russo is Now at SmallCapVoice.com
GlobeNewswire - Tue Dec 30, 7:00AM CST
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with FBC Holding, Inc. (OTC:FBCD) (the "Company" , an international product and development company, is now available. The interview can be heard at http://smallcapvoice.com/blog/12-19-14-smallc...g-inc-fbcd

Darian Braun Signs Deal with Style Network for Reality TV Show about COCO-AMO Hair Care
PR Newswire - Mon Dec 22, 8:29AM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) and its retail health and beauty holding, COCO-AMO has signed a contract with Style Network for the production of a reality television show featuring Darian Braun and the COCO-AMO brand.

FBC Holding, Inc. Announces Leigh Valentine Cosmetic Products Entering Clinical Trials
PR Newswire - Wed Dec 10, 6:30AM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) has announced today it will be taking a new line of skincare products from its cosmetics arm, Leigh Valentine to clinical trials. The company is currently in discussions with reputable organizations that specialize in cosmetics and related protocols necessary to take said products through the trial process.

FBC Holding Inc. Announces Launch of New Corporate Website and Branding
PR Newswire - Wed Dec 03, 9:15AM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) announces the launch of the company's new corporate branding and website- www.fbcd-inc.com

FBC Holding Inc. Signs Sales and Marketing Contract with Leigh Valentine Beauty Cosmetics
PR Newswire - Tue Nov 25, 6:45AM CST
International product and development company, FBC Holding, Inc. (OTC: FBCD) has announced it's signed a contract with the successful health and beauty cosmetics company, Leigh Valentine Beauty to oversee the sales and marketing of its entire product line. The deal represents another significant step for FBC as it expands the companies health and beauty product line. In September, the company launched another health and beauty line with its new holding, COCO-AMO which continues to exceed sales projections both nationally and internationally.

FBC Holding, Inc. Announces National Distribution Deal Larger Than Current Market Cap of Company
PR Newswire - Thu Nov 13, 9:22AM CST
FBC Holding, Inc. (OTC: FBCD) an international product development company and its retail health and beauty holding, COCO-AMO have announced they've received first round purchase orders from online retailer, Miami Bikini Shop for the full line of COCO-AMO. The Miami-based retailer's interest in COCO-AMO increases the far-reaching demand for COCO-AMO. The agreement comes on the heels of the hair care line's expansion into European markets earlier this week.

FBC Holding Inc. and COCO-AMO Receive First International Order
Marketwired - Wed Nov 12, 7:07AM CST
FBC Holding, Inc. (OTC: FBCD) an international product development company and its rapidly expanding retail health and beauty holding COCO-AMO, announced that the company has received its first International order from France.

FBC Looks to Sell COCO-AMO Products Through the Largest Health & Beauty Distributor in the US
Marketwired - Thu Nov 06, 1:18PM CST
FBC Holding, Inc. (PINKSHEETS: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced today that the sales of the LOVE conditioner has lead to the reorder of two additional products to round out the offering on the retailer shelves.

FBC Deal With COCO-AMO Retail Presence With Purchase Order of $7,000
Marketwired - Thu Nov 06, 7:15AM CST
FBC Holding, Inc. (PINKSHEETS: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced that the company received great reviews from a distributor for additional 1,200 units of COCO-AMO products.

FBC and COCO-AMO in Discussion With Distributors About Purchasing 3,500 Units of Product
Marketwired - Wed Oct 29, 7:06AM CDT
FBC Holding, Inc. (PINKSHEETS: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced that the company is in discussions with multiple distributors in the US to purchase COCO-AMO products.

FBC and COCO-AMO to Receive 7,000 Units This Week
Marketwired - Thu Oct 23, 7:05AM CDT
FBC Holding, Inc. (PINKSHEETS: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced that the company will be receiving 7,000 units this week to get into our distribution facility.

FBC Deal With COCO-AMO Increases Sales From Internet Campaign and Launched in Metro New York
Marketwired - Mon Oct 20, 7:58AM CDT
FBC Holding, Inc. (PINKSHEETS: FBCD) ("FBC" or the "Company" an international product development company primarily focused on license/creation management and product sales/distribution through DRTV, announced that the company received great reviews from a retailer that sold over 200 units in just 9 days and over 120 units via the internet campaign in just over 10 days.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading